Bauchspeicheldrüse (C25) - Relative Überlebensraten in Österreich nach Geschlecht (1991-2018)
Diagnose-
periode1)
Risikopopulation2)Überleben nach Diagnose (in Jahren)
N13510
Insgesamt
1991-19953.98717,47,46,15,6
1996-20004.92521,16,84,73,4
2001-20055.59425,28,56,24,7
2006-20106.41830,511,17,45,3
2011-20157.48835,914,310,4-
2016-20184.80539,016,5--
Männer
1991-19951.83417,57,25,44,9
1996-20002.29622,17,55,03,6
2001-20052.63025,38,56,24,8
2006-20103.16131,110,66,95,1
2011-20153.74136,114,510,4-
2016-20182.48340,316,5--
Frauen
1991-19952.15317,27,66,76,2
1996-20002.62920,26,24,53,2
2001-20052.96425,18,46,24,7
2006-20103.25729,911,57,85,5
2011-20153.74735,814,210,4-
2016-20182.32237,616,4--